Trial Profile
Single randomized controlled trial comparing structutal outcome with intravitreal bevacizumab with conventional laser photoablation in infants with retinopathy of prematurity (ROP)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- 03 Nov 2015 New trial record